What is Aprea Therapeutics, Inc. Common stock's Market Cap?

Aprea Therapeutics, Inc. Common stock's Market Cap is $10.2M, based on as-reported figures from SEC (XBRL) filings.

What is Aprea Therapeutics, Inc. Common stock's Enterprise Value?

Aprea Therapeutics, Inc. Common stock's Enterprise Value is -$31.0M, based on as-reported figures from SEC (XBRL) filings.

What is Aprea Therapeutics, Inc. Common stock's EV / EBITDA?

Aprea Therapeutics, Inc. Common stock's EV / EBITDA is 2.3×, based on as-reported figures from SEC (XBRL) filings.

What is Aprea Therapeutics, Inc. Common stock's Net Income (TTM)?

Aprea Therapeutics, Inc. Common stock's Net Income (TTM) is -$12.3M, based on as-reported figures from SEC (XBRL) filings.

What is Aprea Therapeutics, Inc. Common stock's EBITDA?

Aprea Therapeutics, Inc. Common stock's EBITDA is -$13.2M, based on as-reported figures from SEC (XBRL) filings.

What is Aprea Therapeutics, Inc. Common stock's Diluted EPS (TTM)?

Aprea Therapeutics, Inc. Common stock's Diluted EPS (TTM) is -0.98, based on as-reported figures from SEC (XBRL) filings.

What is Aprea Therapeutics, Inc. Common stock's Net Debt?

Aprea Therapeutics, Inc. Common stock's Net Debt is -$41.2M, based on as-reported figures from SEC (XBRL) filings.

Aprea Therapeutics, Inc. Common stock (APRE) Financial Statements

Aprea Therapeutics, Inc. Common stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00Q6Q3KV6

XNAS · usd

0.81▼ 0.02 (-2.86%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.84

Day's Range0.78 – 0.88

52-Week Range0.55 – 1.69

Volume317.7K

Avg Volume384.9K

Share Statistics

Shares Outstanding

Employees8

ExchangeXNAS

Listed2019-10-03

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Aprea Therapeutics, Inc. Common stock (APRE)

What is Aprea Therapeutics, Inc. Common stock's Market Cap?: Aprea Therapeutics, Inc. Common stock's Market Cap is $10.2M, based on as-reported figures from SEC (XBRL) filings.
What is Aprea Therapeutics, Inc. Common stock's Enterprise Value?: Aprea Therapeutics, Inc. Common stock's Enterprise Value is -$31.0M, based on as-reported figures from SEC (XBRL) filings.
What is Aprea Therapeutics, Inc. Common stock's EV / EBITDA?: Aprea Therapeutics, Inc. Common stock's EV / EBITDA is 2.3×, based on as-reported figures from SEC (XBRL) filings.
What is Aprea Therapeutics, Inc. Common stock's Net Income (TTM)?: Aprea Therapeutics, Inc. Common stock's Net Income (TTM) is -$12.3M, based on as-reported figures from SEC (XBRL) filings.
What is Aprea Therapeutics, Inc. Common stock's EBITDA?: Aprea Therapeutics, Inc. Common stock's EBITDA is -$13.2M, based on as-reported figures from SEC (XBRL) filings.
What is Aprea Therapeutics, Inc. Common stock's Diluted EPS (TTM)?: Aprea Therapeutics, Inc. Common stock's Diluted EPS (TTM) is -0.98, based on as-reported figures from SEC (XBRL) filings.
What is Aprea Therapeutics, Inc. Common stock's Net Debt?: Aprea Therapeutics, Inc. Common stock's Net Debt is -$41.2M, based on as-reported figures from SEC (XBRL) filings.